Abstract
The majority of patients with depression also will suffer from a comorbid anxiety disorder that may include panic disorder, obsessive-compulsive disorder, social phobia, or generalized anxiety disorder. The selective-serotonin reuptake inhibitors present an alternative and useful monotherapy in patients with depression and comorbid anxiety disorders. This treatment is likely to be highly cost-effective as well.
Original language | English (US) |
---|---|
Pages (from-to) | 1047-1050 |
Number of pages | 4 |
Journal | American Journal of Managed Care |
Volume | 2 |
Issue number | 8 |
State | Published - 1996 |
ASJC Scopus subject areas
- Health Policy